Assessment of baseline characteristics, glycemic control and oral antidiabetic treatment in Asian patients with diabetes: The Registry for Assessing OAD Usage in Diabetes Management (REASON) Asia study

Journal of Diabetes

Volumn 5, Issue 3, 2013, Pages 309-318

  Vichayanrat, Apichati ^a   Matawaran, Bien J ^b   Wibudi, Aris ^c   Ferdous, Hossain S ^d   Aamir, Azizul Hasan ^e   Aggarwal, Sanjay K ^e,f   Bajpai, Shailendra ^f  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF SANTO TOMAS HOSPITAL   (Philippines)

^c Gatot Subroto Army Hospital   (Indonesia)

^d BIRDEM Hospital   (Bangladesh)

^e Hayatabad Medical Complex ^*  (United States)

^f Becton Dickinson Asia Pacific   (Singapore)

Author keywords

Asia; Oral antidiabetic drugs; Sulfonylurea; Type 2 diabetes mellitus

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; ORAL ANTIDIABETIC AGENT;

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; DIABETES EDUCATION; DYSLIPIDEMIA; FEAR; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL;

ASIA; ORAL ANTIDIABETIC DRUGS; SULFONYLUREA; TYPE 2 DIABETES MELLITUS;

ADMINISTRATION, ORAL; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; FASTING; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; OBESITY; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; REGISTRIES; SULFONYLUREA COMPOUNDS; TREATMENT OUTCOME;

EID: 84881549550     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/1753-0407.12038     Document Type: Article

References (25)

1. Whiting DR, Guariguata L, Weil C, Shaw J. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011; 94: 311-321.
2. World Health Organization. Diabetes programme: Facts and figures. Available from: http://www.who.int/diabetes/facts/world_figures/en/index5.html (accessed 27 March 2013).
3. Winer N, Sower JR. Epidemiology of diabetes. J Clin Pharmacol. 2004; 44: 397-405.
4. International Diabetes Federation. Global burden. The economic impacts of diabetes. Available from: http://www.diabetesatlas.org/content/economic-impacts-diabetes (accessed 27 March 2013).
5. International Diabetes Federation. Economic impact of diabetes. Available from: http://www.idf.org/sites/default/files/Economic_impact_of_Diabetes.pdf (accessed 27 March 2013).
6. Nathan DM, Buse JB, Davidson MB etal. Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy. A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009; 32: 193-203.
7. Stuckey LR, Tiffany RA, Hale LS. Determine rate of compliance with the American Diabetes Association Recommendations in hospitalized patients. In Adler T, Beldona S, Bousfield G etal. (eds). Proceedings of the 3rd Annual GRASP Conference, Wichita State University, 27 April 2007. Wichita State University, Kansas; 2007; 29-30.
8. Coon P, Zulkowsky K. Adherence to American Diabetes Association standards of care by rural health care providers. Diabetes Care. 2002; 25: 2224-2229.
9. Nathan DM. Finding new treatments for diabetes: How many, how fast ... how good? N Engl J Med. 2007; 356: 437-440.
10. Chan JCN, Malik V, Jia W etal. Diabetes in Asia: Epidemiology, risk factors, and pathophysiology. JAMA. 2009; 301: 2129-2140.
11. Ramachandran A, Wan Ma RC, Snehalatha C. Diabetes in Asia. Lancet. 2010; 375: 408-418.
12. Chiang CW, Chiu HF, Chen CY, Wu HL, Yang CY. Trends in the use of oral antidiabetic drugs by outpatients in Taiwan: 1997-2003. J Clin Pharm Ther. 2006; 31: 73-82.
13. Kosachunhanun N, Benjasuratwong Y, Mongkolsomlit S etal. Thailand diabetes registry project: Glycemic control in Thai type 2 diabetes and its relation to hypoglycemic agent usage. J Med Assoc Thai. 2006; 89 (Suppl. 1): S66-71.
14. Tong PC, Ko GT, So WY etal. Use of anti-diabetic drugs and glycaemic control in type 2 diabetes: The Hong Kong Diabetes Registry. Diabetes Res Clin Pract. 2008; 82: 346-352.
15. World Health Organization. Laboratory diagnosis and monitoring of diabetes mellitus. 2002. Available from: http://whqlibdoc.who.int/hq/2002/9241590483.pdf (accessed 27 March 2013).
16. Declaration of Helsinki. Article I.9. Helsinki, Finland: Adopted by the 18th World Medical Assembly, Helsinki, 1964 as amended by the 59th World Medical Assembly, Seoul, 2008. Available from: http://www.wma.net/en/30publications/10policies/b3/ (accessed 27 March 2013).
17. ICH harmonised tripartite guideline. Guideline for good clinical practice E6(R1). 1996. Available from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6_R1/Step4/E6_R1__Guideline.pdf (accessed 27 March 2013).
18. National Institute for Health and Clinical Excellence (NICE). Clinical guidelines. Available from: http://publications.nice.org.uk/type-2-diabetes-cg87/guidance#oral-glucose-control-therapies-1-metformin-insulin-secretagogues-and-acarbose (assessed 27 March 2013).
19. Inzucchi SE. Oral antihyperglycemic therapy for type 2 diabetes: Scientific review. JAMA. 2002; 287: 360-372.
20. The DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med. 1993; 329: 977-986.
21. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications with subjects with type 2 diabetes (UKPDS 33) [published erratum appears in Lancet 1999; 354: 602]. Lancet. 1998; 352: 837-853.
22. Pan CY, Ho LT, Soegondo S etal. Prevalence of albuminuria and cardiovascular risk profile in a referred cohort of patients with type 2 diabetes: An Asian perspective. Diabetes Technol Ther. 2008; 10: 397-403.
23. Wild D, von Maltzahn R, Brohan E, Christensen T, Clauson P, Gonder-Frederick L. A critical review of the literature on fear of hypoglycemia in diabetes: Implications for diabetes management and patient education. Patient Educ Couns. 2007; 68: 10-15.
24. Nesbeth H, Ørskov C, Rosenthall W. Breaking down the barriers to good glycaemic control in type 2 diabetes: A debate on the role of nurses. Eur Diabetes Nursing. 2009; 6: 29-33.
25. Rubin RR. Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus. Am J Med. 2005; 118 (Suppl. 5A): 27S-34S.